000 01504 a2200421 4500
005 20250511174449.0
264 0 _c19760802
008 197608s 0 0 eng d
022 _a0007-0963
024 7 _a10.1111/j.1365-2133.1976.tb02272.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMunro, D D
245 0 0 _aThe effect of percutaneously absorbed steroids on hypothalamic--pituitary--adrenal function after intensive use in in-patients.
_h[electronic resource]
260 _bThe British journal of dermatology
_cMar 1976
300 _a67-76 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a17-Hydroxycorticosteroids
_xurine
650 0 4 _aAdrenal Cortex Hormones
_xpharmacology
650 0 4 _aAdrenal Glands
_xdrug effects
650 0 4 _aAdult
650 0 4 _aBetamethasone Valerate
_xtherapeutic use
650 0 4 _aButyrates
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aFemale
650 0 4 _aFlumethasone
_xtherapeutic use
650 0 4 _aFluocinonide
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHydrocortisone
_xblood
650 0 4 _aHypothalamus
_xdrug effects
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPituitary Gland
_xdrug effects
650 0 4 _aSkin Diseases
_xdrug therapy
773 0 _tThe British journal of dermatology
_gvol. 94 suppl 12
_gp. 67-76
856 4 0 _uhttps://doi.org/10.1111/j.1365-2133.1976.tb02272.x
_zAvailable from publisher's website
999 _c1274610
_d1274610